Lee CM - Search Results

1

Lamivudine treatment for recurrent pancreatitis associated with reactivation of chronic B hepatitis.

Chen CH, Changchien CS, Lu SN, Wang JH, Hung CH, Lee CM. Chen CH, et al. Among authors: lee cm. Dig Dis Sci. 2002 Mar;47(3):564-7. doi: 10.1023/a:1017916119240. Dig Dis Sci. 2002. PMID: 11911343 No abstract available.

2

Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma.

Liao CA, Lee CM, Wu HC, Wang MC, Lu SN, Eng HL. Liao CA, et al. Among authors: lee cm. Br J Haematol. 2002 Jan;116(1):166-9. doi: 10.1046/j.1365-2141.2002.03239.x. Br J Haematol. 2002. PMID: 11841412 Free article.

3

Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.

Lee CM, Ong GY, Lu SN, Wang JH, Liao CA, Tung HD, Chen TM, Changchien CS. Lee CM, et al. J Hepatol. 2002 Nov;37(5):669-74. doi: 10.1016/s0168-8278(02)00267-2. J Hepatol. 2002. PMID: 12399235 Clinical Trial.

4

Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?

Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen TM, Chen CH, Changchien CS. Hung CH, et al. Among authors: lee cm. J Gastroenterol Hepatol. 2002 Dec;17(12):1307-11. doi: 10.1046/j.1440-1746.2002.02874.x. J Gastroenterol Hepatol. 2002. PMID: 12423276

5

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis.

Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, Chen CH, Huang WS, Changchien CS. Hung CH, et al. Among authors: lee cm. J Gastroenterol. 2003;38(2):153-7. doi: 10.1007/s005350300025. J Gastroenterol. 2003. PMID: 12640529

6

Acute hepatitis B virus superinfection in a Taiwanese patient with chronic hepatitis C.

Hung CH, Lee CM, Wang JH, Chen CH, Lu SN. Hung CH, et al. Among authors: lee cm. J Formos Med Assoc. 2004 Apr;103(4):302-5. J Formos Med Assoc. 2004. PMID: 15175827

7

Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants.

Chen CH, Lee CM, Lu SN, Wang JH, Tung HD, Hung CH, Chen WJ, Changchien CS. Chen CH, et al. Among authors: lee cm. J Hepatol. 2004 Sep;41(3):454-61. doi: 10.1016/j.jhep.2004.04.032. J Hepatol. 2004. PMID: 15336449 Clinical Trial.

8

Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.

Tseng PL, Lu SN, Tung HD, Wang JH, Changchien CS, Lee CM. Tseng PL, et al. Among authors: lee cm. J Viral Hepat. 2005 Jul;12(4):386-92. doi: 10.1111/j.1365-2893.2005.00608.x. J Viral Hepat. 2005. PMID: 15985009 Clinical Trial.

9

Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.

Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, Wang JH, Hung CH, Hu TH. Chen CH, et al. Among authors: lee cm. J Hepatol. 2006 Jan;44(1):76-82. doi: 10.1016/j.jhep.2005.08.022. Epub 2005 Sep 23. J Hepatol. 2006. PMID: 16298013

10

Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy.

Hung CH, Kuo FY, Wang JH, Lu SN, Hu TH, Chen CH, Lee CM, Eng HL. Hung CH, et al. Among authors: lee cm. Antivir Ther. 2006;11(4):483-9. Antivir Ther. 2006. PMID: 16856622 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,631 results

Search Page

Filters